Overview of Taiwan’s indigenous ethnopharmacology in the perspective of traditional knowledge protection

详细信息    查看全文

• 作者：Jing-jing Guo ; Wei Pan ; Mei-wan Chen …
• 关键词：ethnopharmacology ; traditional medicine ; traditional knowledge ; Taiwan
• 刊名：Chinese Journal of Integrative Medicine
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：21
• 期：12
• 页码：949-954
• 全文大小：260 KB
• 参考文献：1.Reyes-Garcia V. The relevance of traditional knowledge systems for ethnopharmacological research: theoretical and methodological contributions. J Ethnobiol Ethnomed 2010;6:32-6.PubMedCentral CrossRef PubMed
  2.Xu H, Chen KJ. Complementary and alternative medicine: is it possible to be mainstream Chin J Integr Med 2012;18:403-04.CrossRef PubMed
  3.Dutfield G. Protecting traditional knowledge: pathways to the future. ICTSD Prog IPR Sust Dev 2006;3-.
  4.Tsai C. Traditional knowledge protection of indigenous people. Taiwan Indig Stud Rev 2007;2:1-6.
  5.Tong Y, He W, Zhao Y. World Health Organization Traditional Medicine Policy Review. Chin J Inf Tradit Chin Med (Chin) 2010;17:2-.
  6.Wang JH. Traditional Chinese medicine and the positive correlation with homeostatic evolution of human being: based on medical perspective. Chin J Integr Med 2012;18:629-34.CrossRef PubMed
  7.Tian P. Convergence: where West meets East. Nature 2011;480:84-6.CrossRef
  8.Nalawade SM, Sagare AP, Lee CY, Kao CL, Tsay HS. Studies on tissue culture of Chinese medicinal plant resources in Taiwan and their sustainable utilization. Bot Bull Acad Sin 2003;44:79-8.
  9.Namba T. Current research on traditional medicines and an introduction of ethnopharmacology. J Chin Med 1996;7:59-2.
  10.Xue TH. Trusting in traditional cures. Nature 1996;379:110.CrossRef PubMed
  11.Liang M, Liu Y, Ananda S, Zhuo L, Liu L. Toxicology of Dysosma versipallis rhizome: a review. J Med Plant Res 2010;4:717-21.
  12.Ranilla LG, Kwon YI, Apostolidis E, Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour Technol 2010;101:4676-689.CrossRef PubMed
  13.Ham I, Lee SJ, Kim H, Kang IH, Jin HO, Whang WK. Standardization and seasonal variation of quercetin glycoside in Eucommiae folium. Kor J Pharmacog 2002;33:194-99.
  14.Elly D. A Chinese herbal formula for relief of asthma Focus Altern Complement Ther 2005;10:189-91.
  15.Tamaki A, Ide T, Otsuka H. Phenolic glycosides from the leaves of Alangium platanifolium var. platanifolium. J Nat Prod 2000;63:1417-419.CrossRef PubMed
  16.Shen YX, Teng HL, Yang GZ, Mei ZN, Chen XL. A new chromone derivative from Berchemia lineate. Acta Pharm Sin 2010;45:1139-143.
  17.Broughton A. An overview of Yellow Card reporting by NIMH practitioners. J Herb Med 2011;1:15-9.CrossRef
  18.Heinrich M, Chan J, Wanke S, Neinhuis C, Simmonds M. Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2—a global assessment based on bibliographic sources. J Ethnopharmacol 2009;125:108-44.CrossRef PubMed
  19.Sharma HK, Kumar A. Evaluation of total phenol, flavonoid and in vitro antioxidant activity of methanolic extract of leaves of Melastoma malabathricum linn. Asian J Chem 2011;23:434-38.
  20.Pieroni A, Dibra B, Grishaj G, Grishaj I, Maai SG. Traditional phytotherapy of the Albanians of Lepushe, Northern Albanian Alps. Fitoterapia 2005;76:379-99.CrossRef PubMed
  21.Ho SC, Ho YF, Lai TH, Liu TH, Su SY, Wu RY. Effect of Tianma Gouteng Decoction with subtractive ingredients and its active constituents on memory acquisition. Am J Chin Med 2008;36:593-02.CrossRef PubMed
  22.Sun Q, Shao FX, Li JJ, Wang J, Kou JP, Yu BY. Advances in studies on active components modulating tissue factor in Chinese materia medica. Chin Tradit Herb Drugs (Chin) 2010;41:488-91.
  23.Cheung F. Traditional Chinese medicine: made in China. Nature 2011;480:82-3.CrossRef
  24.Castree N. Bioprospecting: from theory to practice (and back again). Trans Inst Br Geogr 2003;28:35-5.CrossRef
  25.Greene S. Indigenous people incorporated Culture as politics, culture as property in pharmaceutical bioprospecting. Curr Anthropol 2004;45:211-37.CrossRef
  26.Kuo WHJ. A preliminary study on the protection of traditional knowledge. Tsing Hua J Law Technol Policy 2005;2:49-9.
  27.Allred BB, Park WG. Patent rights and innovative activity: evidence from national and firm-level data. J Int Business Stud 2007;38:878-00.CrossRef
  28.Tang L. Patent status of Chinese medicinal herb in foreign countries and registered patents in China by foreigners. Sci Technol Manage Res (Chin) 2010;176-80.
  29.Reid J. Biopiracy: the struggle for traditional knowledge rights. Am Ind Law Rev 2009;34:77-8.
  30.Chowdhury N. Patents bill: protecting indigenous knowledge. Eco Politic Weekly 2004;39:4984-986.
  31.Tedlock B. Indigenous heritage and biopiracy in the age of intellectual property rights. Explore 2006;2:256-59.CrossRef PubMed
  32.Wang T, Che M, Wang Y. Cases study on international traditional medical knowledge rights protection. Chin J New Drugs (Chin) 2006;15:1609-614.
  33.Deardorff A. Welfare effects of global patent protection. Economeica 1992;59:36-1.
  34.Diwan I, Rodrik D. Patents, appropriate technology,
• 作者单位：Jing-jing Guo (1) (2)
  Wei Pan (2)
  Mei-wan Chen (2)
  Chun-ming Wang (2)
  Yi-tao Wang (2)
  
  1. Department of Agronomy, Taiwan University, Roosevelt Road, Taipei, 10617, Taiwan, China
  2. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, 999078, China
  
• 刊物主题：Medicine/Public Health, general;
• 出版者：Springer Berlin Heidelberg
• ISSN：1993-0402

文摘

Ethnopharmacology, the study of ethnic use of drugs, opens up the crucial gateway to understanding and promoting traditional medicine in the new age. Taiwan is a unique region where traditional medicine and herbal therapeutics have been benefiting its people of multiple races for centuries. This article overviews Taiwan’s indigenous traditional medicine and the emerging status of ethnopharmacology study, and outlines the global scenario of the inheritance and development of traditional medicine. In such a scope of knowledge protection, this article particularly highlights the challenges with bioprospecting and biopiracy, and summarizes the current measures for protection of traditional knowledge in Taiwan. Finally, based upon these analyses, we propose rational strategies for promoting Taiwan’s ethnopharmacology, from multiple angles of resource, economy, policy and law. We conclude that four measures, namely (1) protecting the natural environment of biodiversity, (2) avoiding unnecessary conflicts caused by bioprospecting and biopiracy, (3) strengthening the international collaboration, and (4) upgrading the legal system of traditional intelligence, would be the right paths for Taiwan to protect its invaluable heritage of traditional medicine and the knowledge of ethnopharmacology therein. Keywords ethnopharmacology traditional medicine traditional knowledge Taiwan